How to Buy Mesoblast Stock

Mesoblast Ltd

Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies.

Mesoblast stock last closed at $15.48, down 0.13% from the previous day, and has increased 0.72% in one year. It has overperformed other stocks in the Biotechnology industry by 0.15 percentage points. Mesoblast stock is currently +18.62% from its 52-week low of $13.05, and -28% from its 52-week high of $21.50.

As of Sep 11, 2026, there are 1.3B MESO shares outstanding. The market cap of MESO is $2.01B. In the last 24 hours, 180,000 MESO shares were traded.

How to Buy Mesoblast Stock

Not sure how to invest in Mesoblast stock? Here's how.

  1. Decide where to buy Mesoblast stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Mesoblast stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your brokerage account: Choose your payment method and add your details.
  4. Analyze Mesoblast stock: The Mesoblast ticker symbol is MESO. Is Mesoblast stock a good investment? Should you buy shares of MESO? How do MESO's underlying business fundamentals look? Do top analysts think Mesoblast is a good buy? Why has MESO's stock price moved recently? (Hint: Our stock research website can help you understand if MESO is a good stock to buy).
  5. Make your MESO purchase: Decide if you will purchase MESO shares at the current market price or use a limit order to buy MESO stock at a particular price.
  6. Get notifications regarding your MESO position: Create a watchlist to key updates about your investment in Mesoblast shares.

Step 1: Decide where to buy Mesoblast stock

You will need a brokerage account to access the NASDAQ market and buy MESO shares.

A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the right brokerage, you'll need to fill out some personal details so you are able to buy MESO today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to start your new trading account.
  1. Send your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have filled out your info on the best stock investing app, you need to deposit funds:

Watch the tutorial below for more details transferring funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Mesoblast stock

After you have selected the best place to buy Mesoblast stock, it's important to evaluate their stock before you buy, so you actually comprehend the risk as well as the upside.

Mesoblast stock quick numbers

MESO Price
$15.48
1w %
-10.62%
1y %
0.72%
5y %
20.75%
P/E
-34.86x
P/B
3.53x
P/S
16.7x
PEG
N/A
Revenue
$120.25M
Earnings
-$57.50M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$2.01B
Next Earnings
N/A
Next Dividend
N/A

MESO Overview

WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on MESO's stock page.

Is MESO stock undervalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MESO's intrinsic value.

Using relative valuations ratios:

  • MESO could be undervalued based on its P/B ratio of 3.53x, relative to Biotechnology industry P/B ratio of 5.32x

You can access additional valuation analysis on MESO's stock here.

MESO Financial Health

Passed Financial Due Diligence Checks:

  • MESO has $102.91M in cash and short term investments. This is enough to cover its annual cash burn of $44.79M.
  • There are more short-term assets than short-term liabilities on the MESO balance sheet.
  • MESO has cash burn of 44788000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the MESO balance sheet.
  • MESO has a low debt to equity ratio of 0.36.

Failed Financial Due Diligence Checks:

  • MESO profit margin has gone up by 5.46 percentage points in the past year, but the company is still unprofitable.
  • Total MESO debt is higher than 5 years ago, relative to shareholder equity.

Is MESO stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 1 Equities analysts who track MESO, the consensus analyst rating on MESO is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Mesoblast stock forecast page.

MESO Trading Indicators

SMA10
16.6
SMA20
16.78
SMA50
16.11
SMA100
15.44
SMA200
16.13
MACD
0
MACD Signal
0.25
MACD Histogram
-0.25
RSI
42.46
Stochastic %K
3.62
Stochastic %D
8.22
StochRSI %K
0
StochRSI %D
4.39

MESO Earnings

Last year, MESO revenue was $120.25M. During the last 5 year, MESO's revenue has grown by 74.49% per year. This was faster than the Biotechnology industry average of 23.88%.

Find out more about MESO's earnings and revenue performance here.

Are MESO insiders buying or selling the stock?

In the past 12 months, executives and large shareholders at MESO have bought more shares than they have sold.

Gregory George, Director of MESO, was the latest MESO insider to buy. They bought $3,439,626.56 worth of MESO shares on Apr 10, 2026.

Research more about who owns MESO stock here.

Can I rely on MESO as an income stream?

No, Mesoblast doesn't provide an income stream by paying out dividends.

What others are saying about MESO

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Make your MESO purchase

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given price, use a limit order.

Press the Open Trade button and eToro will execute your order.

If you require more help with buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get notifications regarding your MESO position

Now that you own some MESO stock, you'll want to keep up with your new stock purchase.

Make a watchlist to monitor your MESO stock.

MESO Feed

How to Buy Stock in Mesoblast

To summarize, here are the 6 steps you need to take to buy Mesoblast stock right now:

  1. Decide where to buy Mesoblast stock
  2. Open your brokerage account
  3. Put funds into your brokerage account
  4. Analyze Mesoblast stock
  5. Make your MESO purchase
  6. Get notifications regarding your MESO position

If you need a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your investment in Mesoblast, add MESO to your watchlist below.

NASDAQ: MESO
$15.48-0.02 (-0.13%)
Updated Sep 11, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: MESO
$15.48-0.02 (-0.13%)
Updated Sep 11, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Mesoblast share?

As of Sep 11, 2026, it costs $15.48 to buy one share of Mesoblast stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.452 shares of MESO.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Mesoblast stock?

According to 1 Wall Street analysts who monitor Mesoblast, their consensus recommendation is to buy Mesoblast stock.

What is the best way to buy Mesoblast stock?

One way to place an order for Mesoblast stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.